News releases | Medicago

Medicago

Menu
  • Our company
    Our company
    • Our history
    • Our mission and values
    • Our commitment to ethics
    • Our pandemic response
    • Our leadership team
    • Our locations
    • Our partners
  • Our science
    Our science
    • Your health
    • Our R&D pipeline
    • Our clinical trials
    • Our vaccine candidates
    • Our therapeutic antibody research
  • Our technologies
    Our technologies
    • Plant-based technology
    • Our technology illustrated
    • Virus-like particles
  • Our vaccines
    Our vaccines
    • Covifenz
    • Reporting side effects
  • Media
  • Careers
  • Culture
  • FAQ
  • Contact
  • fr
  • News releases

News releases

  • All
  • Antibodies 1
  • Corpo 8
  • Vaccine 19
  • Clinical trials 7
  • COVID-19 17
    • Corpo
    April 28, 2022

    Medicago announces the appointment of Toshifumi Tada as President and CEO

    Press release 2022
    Read more
    • Corpo
    December 4, 2020

    Takashi Nagao appointed president and chief executive officer of Medicago

    Press release Medicago 2020
    Read more
    • Corpo
    • Vaccine
    • COVID-19
    October 23, 2020

    Medicago signs agreements with the government of Canada to supply up to 76 million doses of its recombinant plant-derived COVID-19 vaccine

    Press release Medicago 2020
    Read more
    • Corpo
    • Vaccine
    May 5, 2020

    Collaborative project of more than $1.2 million using artificial intelligence to optimize the production of vaccines, announced by CQDM and Medicago R&D

    Press release Medicago 2020
    Read more
    • Corpo
    November 5, 2019

    A Medicago employee named one of CASCON X Evoke Canada’s Tech Titans: Top 19 of 2019

    Press release Medicago 2019
    Read more
    • Corpo
    April 25, 2019

    Medicago awarded « Best New Vaccine Technology/Platform » at the World Vaccine Congress

    Press release Medicago 2019
    Read more
    • Corpo
    September 18, 2018

    Medicago officially starts the construction of its site in Estimauville’s Innovation Area

    Press release Medicago 2018
    Read more
    • Corpo
    May 19, 2015

    Medicago to build $245M production facility in Quebec City

    Press release Medicago 2015-2017
    Read more
Medicago
  • Media
  • Careers
  • Culture
  • FAQ
  • Contact
  • Our company
    Our company
    • Our history
    • Our mission and values
    • Our commitment to ethics
    • Our pandemic response
    • Our leadership team
    • Our locations
    • Our partners
  • Our science
    Our science
    • Your health
    • Our R&D pipeline
    • Our clinical trials
    • Our vaccine candidates
    • Our therapeutic antibody research
  • Our technologies
    Our technologies
    • Plant-based technology
    • Our technology illustrated
    • Virus-like particles
  • Our vaccines
    Our vaccines
    • Covifenz
    • Reporting side effects
  • Legal
  • Privacy
  • Community guideline
  • Cookie policy
© Medicago Inc, 2022

This website uses cookies. Find out more

You are leaving a Medicago website

Medicago does not review or control the content of non-Medicago websites, and this link does not constitute an endorsement by Medicago of that site’s content.